<DOC>
	<DOCNO>NCT01949454</DOCNO>
	<brief_summary>The investigator aim evaluate new potentially cost-effective approach improve trichiasis surgery outcomes , perioperative topical anti-inflammatory therapy . The investigator hypothesize adjunctive topical fluorometholone therapy follow trichiasis surgery reduce risk recurrent trichiasis . The rationale hypothesis interruption inflammation postoperatively would reduce postoperative scarring , lead good outcome . As initial step toward evaluate modality , investigator believe necessary evaluate topical corticosteroid therapy safety-oriented study , investigator also hypothesize fluorometholone perioperative safety profile acceptable large-scale programmatic use . Topical corticosteroid therapy associate potential risk cataract induction intraocular pressure ( IOP ) elevation susceptible individual . Fluorometholone low intraocular penetration alternative corticosteroid , correspondingly less IOP-raising effect still favorable effect conjunctival inflammation , low-cost generic drug . Its poor delivery corticosteroid eye provide advantage setting , major side effect therapy result intraocular effect , therapy need conjunctiva . However , prior use large-scale trial sensible make sure adverse outcome observe substantial number TT patient small scale trial . Secondary goal trial evaluate alternative topical corticosteroid dose schedule identify optimal dose schedule identify preliminary signal potential efficacy .</brief_summary>
	<brief_title>Fluorometholone Ancillary Therapy TT Surgery</brief_title>
	<detailed_description>Protocol Title : Fluorometholone 0.1 % Perioperative Adjunct Therapy Lid-rotation Surgery Trachomatous Entropion Trichiasis , Dose-varying Study Study Design : Randomized , double-masked , dose-ranging study three dose level fluorometholone 0.1 % placebo one eye subject trachomatous trichiasis ( TT ) undergo lid rotation surgery Primary Study Objective : Evaluate safety tolerability three ( 3 ) dose fluorometholone 0.1 % subject trachomatous trichiasis ( TT ) undergo lid rotation surgery ( Bilamellar Tarsal Rotation ) Secondary Study Objective : Conduct preliminary assessment efficacy three ( 3 ) dose fluorometholone 0.1 % subject trachomatous trichiasis ( TT ) undergo lid rotation surgery ( Bilamellar Tarsal Rotation ) Number Subjects : Up 156 eye 156 subject Study Population : Subjects trachomatous trichiasis ( TT ) undergo lid rotation surgery ( Bilamellar Tarsal Rotation ) Test Articles : 1 . Fluorometholone 0.1 % one drop twice daily four week 2 . Placebo one drop twice daily four week 3 . Fluorometholone 0.1 % one drop four time daily four week 4 . Placebo one drop four time daily four week 5 . Fluorometholone 0.1 % one drop four time daily eight week 6 . Placebo one drop four time daily eight week Visit Schedule : Following trichiasis surgery Day 0 , subject return study visit approximately Days 14 , 28 , 56 , 90 , 365 Tolerability Parameters : - Treatment-emergent ocular symptoms/signs - Discontinuation drug / treatment side effect Safety Parameters : - Intraocular pressure elevation â‰¥30 mm Hg - Cataract - Adverse event - Treatment emergent abnormal ophthalmic finding - Treatment emergent external examination finding - Visual acuity Efficacy Parameters : - Trichiasis recurrence - Entropion recurrence - Trachoma activity grade ( extent activity grade eye severe trachomatous scar )</detailed_description>
	<mesh_term>Trachoma</mesh_term>
	<mesh_term>Trichiasis</mesh_term>
	<mesh_term>Fluorometholone</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Age 18 year 2 . Diagnosis trachomatous trichiasis 3 . Plan lid rotation surgery ( Bilamellar Tarsal Rotation ) least one upper eyelid 4 . LOCS 3 cataract grade level 3 less nuclear cataract scale , level 2 le cortical cataract posterior subcapsular cataract scale . 5 . Intraocular pressure 820 mm Hg study eye . 1 . Contraindications use test article 2 . Known allergy sensitivity medication use study , include study medication component ( e.g. , fluorometholone ) 3 . Currently take two ocular antihypertensive medication study eye ( prior IOPlowering surgery acceptable ; combination two agent Cosopt Combigan consider two medication ) 4 . Glaucoma sufficiently advance intraocular pressure spike potentially would put patient substantial risk vision loss , per study ophthalmologist 's judgment . 5 . Nonphakic ( i.e. , pseudophakic aphakic ) study eye ( contralateral nonphakic eye permit ) . 6 . Other trachoma , active ocular infection ( bacterial , viral , fungal ) , active ocular inflammation ( e.g. , scleritis , iritis ) . 7 . History diagnosis ocular herpes presence corneal lesion suspect herpetic origin ; diagnosis suspect diagnosis ophthalmic mycobacterial infection either eye . 8 . Corneal scleral thin either eye . 9 . A severe / serious ocular pathology medical condition may preclude study completion . 10 . Any condition anticipate ocular systemic corticosteroid therapy would require . 11 . Unwilling discontinue use contact lenses duration study ( unusual circumstance trachomatous trichiasis patient use contact lens encounter ) 12 . Any significant illness condition could , investigator 's subinvestigator 's opinion , expect interfere study parameter study conduct ; put subject significant risk 13 . For woman childbearing age , currently pregnant and/or breastfeeding , obtain selfreport ( concern ( programmatic ) use azithromycin set ) . 14 . Cataract study eye , define LOCS3 cataract grade level 3.1 nuclear cataract scale , level 2.1 cortical cataract posterior subcapsular cataract scale .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>trachoma</keyword>
	<keyword>trichiasis</keyword>
	<keyword>trachomatous trichiasis</keyword>
	<keyword>bilamellar tarsal rotation</keyword>
	<keyword>fluorometholone</keyword>
	<keyword>placebo control</keyword>
</DOC>